Characterisation of Agonist-Receptor Interaction: Occupancy, Affinity, Dose-Response Curve, Potency, Efficacy Flashcards
Types of Receptor Ligands
Agonist
Full Agonist: can evoke maximal effect
Partial Agonist: evokes submaximal effect
Antagonist
Allosteric Modulator
Inverse Agonist
‘Equation’ of Agonist Action
Agonist + Free Receptor Agonist Receptor Complex
Agonist Receptor Complex –> Activated Agonist-R Comp.
Activated Agonist-R Complex–> Effect
Concentration- Occupancy Relationship
Agonist + Free Receptor Agonist Receptor Complex
Definition of Occupancy
Fraction or percentage of receptors occupied by agonist
Hill Langmuir Equation
p= Nl/Nt = c/ (c+(k2/k1)) = c/ (c+Kd)
p= Receptor occupancy Nl= # Ligand Bound Rs Nt= total # receptors
c= ligand conc k2= Rate constant for dissociation k1= Rate constant for association
Kd= equilibrium dissociation constant of agonist-R compl.
Ligand conc. causing 50% occupancy
Conclusions based on the Hill Langmuir Equation
Occupancy depends on
Ligand concentration and Kd
With high ligand concentrations occupancy approaches 1
Ergo: Ligand binding is saturable
Graphical form of Hill Langmuir Equation
Sigmoid shaped using log scale
(hyperbola in normal conc scale)
Y Axis: Occupancy (%)
X Axis: log Conc
Turning point of sigmoid shape: Kd: 50% occupancy
Kd
Characterises binding tendency of ligand–> affinity
Inversely proportional: Increase Kd, decrease affinity
High affinity-> high selectivity
Ligand binds to target R at low conc
Fewer SEs
EC50: Agonist conc. evoking 50%
Characterises potency of drug
Concentration- Response Curves
Full Agonists
Partial Agonist with IA=0.5
Antagonist
Full Agonists reach 100% Effect; full height sigmoid
Middle part near linear
Partial Agonist with IA=0.5 (can be between 0 and 1)
Only reaches 50% Effect; half sized sigmoid
Less steep–> larger margin of safety
Antagonist
Line at bottom; doesn’t reach any effect
Potency Rank:
A, B> C
C will require higher dose for still lower effect
Parameters of Concentration- Response Curve
Maximum of curve= efficacy
Expressed by IA
Clinical sig: determines how severe symp/ diseases
can be treated.
More severe–> need more efficacious drug
Position of curve along conc/dose axis: Potency Conc/dose req to induce given effect Drug needing lower conc is more potent EC 50 (conc) or ED50 (dose) Determines dosing: less potent-> higher conc needed
Slope of near-linear middle part of curve
Indicated how large increase of effect prod. by
increasing conc.
Related to margin of safety: steeper- smaller margin
Affinity
Potency
Efficacy
Intrinsic Activity
Affinity
Binding tendency of a ligand
Inversely proportional to Kd
Can only be compared when drugs bind same R
Potency
Conc. of dose req to induce given effect
Lower dose-> higher potency; characterised by ED50
Dep on affinity, signal amplification, R density, intrinsic
efficacy
Efficacy
Max of curve, max effect provoked by drug
Expressed by IA
Dep on intrinsic efficacy, signal amplification, R density
Intrinsic Activity
(Max Effect Inducible by drug) / (max effect possible in
given tissue)
Range 0-1
Receptor Reserve
Max effect that can be elicited with submaximal R occupancy: R reserve is fraction of Rs that are apparently not req for maximal effect
May be due to
High signal amplification during signal transduction
High R density
(High intrinsic efficacy of agonist)
Receptor downreg doesn’t decrease max. effect of full agonist (until certain limit)
Effect of R down-regulation on full agonist
Decrease in potency and efficacy
Sigmoid curve decreases in size and shifts to right (need higher concentration)
Intrinsic Efficacy
Describes receptor activating ability/ power of agonist
Describes how efficiently R occupancy translates into effect
Higher intrinsic efficacy-> increase efficacy until max possible effect of tissue reached
After: appearance and increase in receptor reserve
On curve:
Increased intrinsic efficacy-> shift to the left
Unlike IA: doesn’t have upper value: suitable to distinguish between R activating abilities of full agonists
Factors determining effect of an agonist
Number of activated Rs
Intrinsic efficacy